🇺🇸 FDA
Patent

US 10835604

Biomaterials for combined radiotherapy and immunotherapy of cancer

granted A61KA61K39/00A61K41/0038

Quick answer

US patent 10835604 (Biomaterials for combined radiotherapy and immunotherapy of cancer) held by Northwestern University expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K39/00, A61K41/0038, A61K47/6923, A61K47/6929